ACCESSION: MSBNK-SMB_Measured-HSA001P0213023
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 19
COMMENT: RAW_SPEC {'7_posi_11506': {'bp': 121772.0, 'sum': 454810.0}, '18_posi_12073': {'bp': 97037.0, 'sum': 392849.0}, '16_posi_11590': {'bp': 90944.0, 'sum': 304983.0}, '1_posi_11486': {'bp': 98994.0, 'sum': 378515.0}, '7_posi_11822': {'bp': 107046.0, 'sum': 377867.0}, '7_posi_11695': {'bp': 92441.0, 'sum': 346494.0}, '6_posi_11570': {'bp': 95584.0, 'sum': 333623.0}, '11_posi_11463': {'bp': 97820.0, 'sum': 394488.0}, '12_posi_11423': {'bp': 100118.0, 'sum': 366887.0}, '17_posi_11444': {'bp': 91170.0, 'sum': 395799.0}, '9_posi_12092': {'bp': 95317.0, 'sum': 350028.0}, '8_posi_11675': {'bp': 81625.0, 'sum': 321451.0}, '9_posi_11885': {'bp': 96312.0, 'sum': 343697.0}, '10_posi_11482': {'bp': 95405.0, 'sum': 339816.0}, '5_posi_11987': {'bp': 91472.0, 'sum': 335721.0}, 'BLK01_11829': {'bp': 102719.0, 'sum': 453873.0}, '1_posi_11717': {'bp': 111285.0, 'sum': 421448.0}, '5_posi_11610': {'bp': 99249.0, 'sum': 361980.0}, '5_posi_12073': {'bp': 91500.0, 'sum': 359169.0}}
COMMENT: RETENTION_TIME_STDEV 0.461
COMMENT: PRECURSOR_M/Z_RAW 213.170569
COMMENT: PRECURSOR_M/Z_STDEV 0.000060
COMMENT: PRECURSOR_IN_MS1 mz 213.170939; int 74.382; delta(ppm) 1.070724
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 254.197474; int 42.430; cor 0.689
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 254.197474; int 42.430; cor 0.689
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 254.197474; int 42.430; cor 0.689
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.226; C10H20N4O; [M+H]+; delta(ppm) -0.226240
COMMENT: PROPOSED_MF SevenGoldenRules 0.269; C8H17N3O; [M+ACN+H]+; delta(ppm) -0.268790
COMMENT: PROPOSED_MF MS-FINDER 3.023; C8H17N3O; [M+ACN+H]+; delta(ppm) 75819.404317
COMMENT: PROPOSED_MF MS-FINDER 2.608; C10H20N4O; [M+H]+; delta(ppm) -0.228556
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.721; C8H17N3O; [M+C2H3N+H]+; delta(ppm) -0.228556
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.721; C10H20N4O; [M+H]+; delta(ppm) -0.228556
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.626; C10H24NO2; [M+Na]+; delta(ppm) 44017.863764
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.649; C10H19O2; [M+C2H3N+H]+; delta(ppm) -6.527044
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.649; C12H22NO2; [M+H]+; delta(ppm) -6.527044
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.339; C6H15N6; [M+C2H3N+H]+; delta(ppm) 6.070011
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.339; C8H18N7; [M+H]+; delta(ppm) 6.070011
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H17N3O; [M+C2H3N+H]+; delta(ppm) -0.228556
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H24NO2; [M+Na]+; delta(ppm) 44017.863764
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H20N4O; [M+H]+; delta(ppm) -0.228556
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.896; MHCILZYUJICANU-GIVGEFRWNA-N; [M+ACN+H]+; UNPD81363
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MHCILZYUJICANU-GIVGEFRWNA-N; [M+ACN+H]+; UNPD81363
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.031; IFVRGSVHHSCKIS-UHFFFAOYSA-N; [M+ACN+H]+; N'-hydroxy-3-piperidin-1-ylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.545; JJEMPZXXGBIJIX-UHFFFAOYSA-N; [M+ACN+H]+; N,N-dimethyl-2-piperazin-1-ylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.279; UVQCDRALXOGZQF-UHFFFAOYSA-N; [M+ACN+H]+; 2-methyl-2-piperazin-1-ylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.273; JNGRMEMVULIXBF-UHFFFAOYSA-N; [M+ACN+H]+; N-ethyl-4-methylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.137; AVEQCXBQACLXDJ-UHFFFAOYSA-N; [M+ACN+H]+; 4-(ethylamino)piperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.136; JJRVDRJMXJJPDM-UHFFFAOYSA-N; [M+ACN+H]+; N-propan-2-ylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.038; VHKDFUCTAJWSQN-UHFFFAOYSA-N; [M+ACN+H]+; 4-(dimethylamino)piperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; FMLZDRMKPOUTQO-UHFFFAOYSA-N; [M+ACN+H]+; 2-(azepan-1-yl)-N'-hydroxyethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; GVZDABQVSXRGAK-UHFFFAOYSA-N; [M+ACN+H]+; N'-hydroxy-2-(2-methylpiperidin-1-yl)ethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.980; MPPMMKDXSXSUTG-UHFFFAOYSA-N; [M+ACN+H]+; 2-(4-aminopiperidin-1-yl)-N-methylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.969; WKHFGQLWQPTVJR-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-N-(1-methylpiperidin-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.949; SDMVZBFFDFADJN-UHFFFAOYSA-N; [M+ACN+H]+; 4-(2-hydroxyethyl)piperidine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.941; SCHUXUBXKBRDDQ-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-(1-methylpiperidin-4-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.936; JDZQCVNSMIOFBW-UHFFFAOYSA-N; [M+ACN+H]+; N'-(1-methylpiperidin-4-yl)acetohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.934; NKIOHORMYZJSGT-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-[(1-methylpyrrolidin-3-yl)methyl]urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.922; QQZGDEIJFYLUIT-ZETCQYMHSA-N; [M+ACN+H]+; (2S)-1-(3-aminopropyl)pyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.915; FWUDIPGDIBVLGN-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-(piperidin-4-ylmethyl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.906; CGPUPBFQFZRKOG-UHFFFAOYSA-N; [M+ACN+H]+; 1-[3-(dimethylamino)propyl]imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.563; JJQYLNCTJNLITN-UHFFFAOYSA-N; [M+ACN+H]+; 2-(dimethylamino)-1-piperazin-1-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.421; CKRGUQFETZTMME-UHFFFAOYSA-N; [M+ACN+H]+; 2-(methylamino)-1-(4-methylpiperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.377; OUVVCIBIGUCHRM-UHFFFAOYSA-N; [M+ACN+H]+; N,N,4-trimethylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.304; IEXLKUJTTDIYQW-UHFFFAOYSA-N; [M+ACN+H]+; 1-[4-(2-aminoethyl)piperazin-1-yl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.219; HNWCTCGGYQCMQS-UHFFFAOYSA-N; [M+ACN+H]+; 3-amino-1-(4-methylpiperazin-1-yl)propan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; YBSDBDDIAPKFNU-UHFFFAOYSA-N; [M+ACN+H]+; 1-[2-(dimethylamino)ethyl]piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.095; WPFYTYMNLMYXOM-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-1-(4-ethylpiperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; RULVDGROGOLQOM-UHFFFAOYSA-N; [M+ACN+H]+; 2-[3-(oxolan-2-yl)propyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; QFQBCYRVCKQHGI-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-[3-(methylamino)propyl]imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; QEHUQVCNWYOKPR-UHFFFAOYSA-N; [M+ACN+H]+; 3-[2-(dimethylamino)ethyl]-5-methylimidazolidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; ZSKQKQLNOZOOFP-UHFFFAOYSA-N; [M+ACN+H]+; 3-amino-N,N-dimethylpiperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; DPWUPATVIQFUKF-UHFFFAOYSA-N; [M+ACN+H]+; 1,1,3-trimethyl-3-pyrrolidin-3-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; WHNXFFIKKJESQD-UHFFFAOYSA-N; [M+ACN+H]+; 1-(2-methylpropyl)-4-nitrosopiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -98.002; ULONOVYBCVNGCJ; [M+C2H3N+H]+; N'-[(3Z)-3-hydroxyimino-2-methylpropyl]-N-propylmethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.479; ZCIVDJYXHTXHRJ; [M+C2H3N+H]+; N-[(4-methylpiperazin-1-yl)methyl]ethanimine oxide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -130.013; RECGNCAKHBFQDU; [M+C2H3N+H]+; N-[2-[(1-amino-2-methylpropylidene)amino]ethyl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -132.500; SPIQDTWYECADJS; [M+C2H3N+H]+; Piperazinone,1,3,3,4-tetramethyl-,oxime,(E)-(9ci)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -135.526; WQOQNJSUJCMTFI; [M+H]+; N-(3-azido-2,2-dimethylpropyl)-2,2-dimethylpropanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -136.120; IYCZWOPUVMFCSB; [M+C2H3N+H]+; 3-(2-Amino-2-methylpropylimino)-2-butanoneoxime
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -136.281; HMRHTVXUCJHGDN; [M+C2H3N+H]+; (NE)-N-[(4-propan-2-ylpiperazin-1-yl)methylidene]hydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -140.618; CUKHCNCBBSTWTG; [M+C2H3N+H]+; 1-(2-Methyl-1-nitrosopropan-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -140.782; KWIGQURJQKXXJV; [M+C2H3N+H]+; (NE)-N-[1-(4-methyl-1,4-diazepan-1-yl)ethylidene]hydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -141.830; NBPMBUMRCIBTAH; [M+C2H3N+H]+; (2E)-N'-butyl-2-hydroxyimino-N,N-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -143.310; PWOXCZCIGIVGIW; [M+C2H3N+H]+; [1-(2-Hydroxyethyl)-3-methylimidazolidin-2-ylidene]-dimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -151.317; WCWLKDWNEQZVPL; [M+H]+; N-(4-azidobutyl)-2,2-dimethylbutanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -162.692; ZBLQDAPOEGXMHM; [M+H]+; 3-[5-[2-(dimethylamino)ethyl]-1,2,4-oxadiazol-3-yl]-N-methylpropan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -162.975; HTNVOVZACQJNSM; [M+H]+; 4-azido-N-(2,2-dimethylbutyl)butanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.968; GWHDKLLUSFQRAY; [M+H]+; 2-methoxy-N-[[4-(2-methylpropyl)-1,2,4-triazol-3-yl]methyl]ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -165.049; ZPHXGXCSCVIIBE; [M+H]+; N,N'-dimethyl-N'-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -165.187; XSKHLAHGZKTOJU; [M+H]+; N',N'-dimethyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]butane-1,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.529; KYSNXQQLNMMXJA; [M+H]+; N-[[4-(2-methoxyethyl)-1,2,4-triazol-3-yl]methyl]-2-methylpropan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -168.335; DHHGKPWDGZLWDM; [M+H]+; N-[[2-(3-methoxypropyl)-1,2,4-triazol-3-yl]methyl]propan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -168.420; MJKOUCSRBSMRQT; [M+H]+; n,n-Dimethyl-n'-(3-propyl-[1,2,4]oxadiazol-5-yl)-propane-1,3-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.245; ULONOVYBCVNGCJ; [M+C2H3N+H]+; N'-[(3Z)-3-hydroxyimino-2-methylpropyl]-N-propylmethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.159; WQOQNJSUJCMTFI; [M+H]+; N-(3-azido-2,2-dimethylpropyl)-2,2-dimethylpropanamide
COMMENT: CONFIDENCE Level 5: Exact mass of interest 213.170939; Observed in MS1; Charge state Unknown;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 23.493
MS$FOCUSED_ION: PRECURSOR_M/Z 213.170939
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-0690000000-5a5305bfbfeb15be5bf1
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  86.0599922 134.7596 ? 86.060459 1.3479 28.29 0.6263 19
  97.0759730 61.2336 ? 97.076318 1.5967 14.02 0.3893 15
  111.0916612 287.7778 ? 111.091877 0.8642 38.48 0.4386 19
  127.0867668 52.2789 ? 127.086779 2.9035 15.19 -0.0515 17
  127.1105822 65.3303 ? 127.110594 2.3208 20.94 -0.1324 16
  128.1182563 62.0134 ? 128.118254 1.4440 13.90 0.1735 16
  129.1023293 134.0099 ? 129.102312 1.3478 16.39 0.4649 19
  140.1183258 87.5124 ? 140.118230 2.2624 27.32 0.3351 19
  143.0816193 62.9502 ? 143.081522 2.5300 18.65 0.2579 19
  183.1129980 118.1556 ? 183.112875 1.7912 24.97 0.4965 19
  195.1602972 420.4126 ? 195.160166 1.0965 41.87 0.5281 19
  213.1429264 362.9407 ? 213.142784 4.8371 59.47 0.3870 18
  213.1711100 999.0000 ? 213.170968 0.5629 0.00 1.0000 19
  213.1904774 458.4832 ? 213.190335 1.1258 83.13 0.3860 19
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  86.059992 134.76 134
  97.075973 61.23 61
  111.091661 287.78 287
  127.086767 52.28 52
  127.110582 65.33 65
  128.118256 62.01 62
  129.102329 134.01 134
  140.118326 87.51 87
  143.081619 62.95 62
  183.112998 118.16 118
  195.160297 420.41 420
  213.142926 362.94 362
  213.171110 999.00 999
  213.190477 458.48 458
//
